Skip to content
10-K

Annual Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-13-018846

← back to feed
Filed
Apr 1, 2013 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2012 · Mar 28, 2013 21.63M sh
Operating Cash Flow FY 2012 · Dec 31, 2012 −$1.55M
Operating Cash Flow FY 2012 · Dec 31, 2011 −$1.61M
Current Liabilities FY 2012 · Dec 31, 2011 $2.31M
Current Assets FY 2012 · Dec 31, 2011 $2.18M
Total Assets FY 2012 · Dec 31, 2011 $2.19M
Sga Expense FY 2012 · Dec 31, 2011 $1.04M
Rd Expense FY 2012 · Dec 31, 2011 $1.16M
Net Income FY 2012 · Dec 31, 2011 −$2.03M
Operating Income FY 2012 · Dec 31, 2011 −$2.2M
Revenue FY 2012 · Dec 31, 2011 $0
Cash And Equivalents FY 2012 · Dec 31, 2010 $3.52M
Stockholders Equity FY 2012 · Dec 31, 2010 $1.66M